Tech Company Financing Transactions
Indi Molecular Funding Round
On 9/21/2013, Indi Molecular raised $1.5 million in Seed funding from InterWest Partners and private investors.
Transaction Overview
Company Name
Announced On
9/21/2013
Transaction Type
Venture Equity
Amount
$1,500,000
Round
Seed
Investors
InterWest Partners (Lead Investor) (Douglas Fisher)
Proceeds Purpose
The funds will be used to further develop PCC (protein catalyzed capture) agent technology: a breakthrough process that produces synthetic peptide molecules capable of binding interactions that are equivalent or superior to molecular antibodies.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
6160 Bristol Pkwy. 200
Culver City, CA 90230
USA
Culver City, CA 90230
USA
Phone
Website
Email Address
Overview
Indi Molecular is an emerging life sciences company that is developing a synthetic class of diagnostic and therapeutic agents with antibody-like properties: protein-catalyzed capture agents.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Albert Luderer
VP - Bus. Development
Michael Klimas
VP - R & D
Heather Agnew
Browse more venture capital transactions:
Prev: 9/21/2013: General Sentiment venture capital transaction
Next: 9/23/2013: Peloton Technology venture capital transaction
Share this article
News on VC Transactions
We do our best to report on tech company VC transactions. All VC database entries on this site are derived from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs